EUGC Sets Last Pin On Pharma Reverse Payment Patent Deals
On October 18, 2023, the General Court of the European Union issued a judgement wherein it went on to reject the appeal made by...
US Patent Law Suit For Actemra Solved Between Roche & Biogen
Based on a filing on October 23 in Massachusetts federal court, Roche, the Swiss pharmaceutical giant, has reached a settlement in a patent lawsuit...
IP Waivers, Pathogen Sharing Benefits In Draft Pandemic Deal
The draft pandemic accord, which was sent to member states of the World Health Organisation by the Intergovernmental Negotiating Body recently, includes several important...
Innovation Can Grow When Big Pharma & Big Tech Collaborate
Big tech along with Big Pharma have gone on to play a crucial role in elevating standards of living as well as shaping the modern age.
Over...
CDMO-Biotech Ties Help Cut Business Risk In Drug Development
Biotech companies go on to face numerous challenges, particularly while in the clinical phase of drug development, in today's fast-paced industry. The astronomically high...
Drug Delivery Via Drones – Get Ready For Exciting Times Ahead
The healthcare industry is experiencing prominent changes because of the rapid advancement of tech. Artificial intelligence- AI is already playing a pivotal role in...
APAC Pandemic Readiness – A Workforce Training Efforts Goal
The Ministry of Health and Welfare in South Korea has gone on to announce a collaborative effort with the Asian Development Bank to carry...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...